From: A bibliometric analysis of the cannabis and cannabinoid research literature
Author keyword | Frequency | % |
---|---|---|
Cannabis | 5171 | 17.35% |
Marijuana | 2876 | 9.65% |
Cannabinoids | 1998 | 6.70% |
Cannabinoid | 1417 | 4.75% |
Cannabidiol | 1237 | 4.15% |
THC | 604 | 2.03% |
Alcohol | 571 | 1.92% |
Schizophrenia | 529 | 1.78% |
Cannabis Sativa | 486 | 1.63% |
Anandamide | 467 | 1.57% |
Synthetic Cannabinoids | 448 | 1.50% |
Adolescents | 436 | 1.46% |
Cannabinoid Receptors | 434 | 1.46% |
Cannabinoid Receptor | 419 | 1.41% |
Adolescence | 409 | 1.37% |
Psychosis | 395 | 1.33% |
Endocannabinoids | 383 | 1.29% |
Medical Marijuana | 356 | 1.19% |
Tetrahydrocannabinol | 350 | 1.17% |
Cannabis Use | 348 | 1.17% |
Pain | 343 | 1.15% |
Tobacco | 327 | 1.10% |
Anxiety | 313 | 1.05% |
Endocannabinoid System | 311 | 1.04% |
Endocannabinoid | 307 | 1.03% |
Substance Use | 304 | 1.02% |
Marijuana Use | 299 | 1.00% |
Inflammation | 292 | 0.98% |
CBD | 280 | 0.94% |
CB1 Receptor | 275 | 0.92% |
Hemp | 275 | 0.92% |
CB1 | 272 | 0.91% |
Rat | 268 | 0.90% |
Depression | 256 | 0.86% |
Adolescent | 248 | 0.83% |
Cognition | 244 | 0.82% |
Addiction | 242 | 0.81% |
Medical Cannabis | 236 | 0.79% |
Hippocampus | 226 | 0.76% |
Δ9-Tetrahydrocannabinol | 223 | 0.75% |
Dependence | 214 | 0.72% |
Rimonabant | 212 | 0.71% |
Cannabis Use Disorder | 211 | 0.71% |
Cocaine | 207 | 0.69% |
Epilepsy | 191 | 0.64% |
Treatment | 191 | 0.64% |
Synthetic Cannabinoid | 179 | 0.60% |
Epidemiology | 178 | 0.60% |
Multiple Sclerosis | 178 | 0.60% |
Legalization | 177 | 0.59% |
Neuroprotection | 170 | 0.57% |
Dopamine | 163 | 0.55% |
Young Adults | 160 | 0.54% |
CB2 | 158 | 0.53% |
Obesity | 158 | 0.53% |
Pregnancy | 156 | 0.52% |
Memory | 150 | 0.50% |
Smoking | 149 | 0.50% |
Cancer | 144 | 0.48% |
Withdrawal | 139 | 0.47% |